IMCAS EDUCATIONAL GRANT PROGRAM

Transcription

1 IMCAS EDUCATIONAL GRANT PROGRAM

2 What is IMCAS? Why is IMCAS eligible? Since 1994, IMCAS has dedicated to providing top quality educational content for plastic surgeons, dermatologists and medical professionals in the medical aesthetics market. With five worldwide meetings and over 550 hours of learning per year, IMCAS has established itself as one of the most prestigious meetings in in the world of this specialty. Why support IMCAS? In an area that is rapidly evolving, physicians need to keep their knowledge up to date with the latest developments, innovations and techniques. With hundreds of CME accredited hours of learning over the course of five worldwide congresses, IMCAS have been filling these educational needs of over 10,000 participants from over 170 countries globally and benefiting countless number of patients. While IMCAS is constantly striving to improve, your support will empower the mission to achieve the highest quality of teaching. Where does the funding go? The grant received will be allocated directly to the educational content delivery and activities associated, with a core purpose to increase understanding of scientific and clinical issues. Gathering these tangible assets, IMCAS is able to bring intangible result that ultimately benefits the patients. Additionally, grantors can support specific topics or sessions within the meeting (for example anatomy or clinical dermatology sessions) or specific provisions or demographics within the meeting (for example funding registration fee waivers for young physicians/residents). In gratitude of the grantors generosity, an acknowledgment can be featured within the meeting program or signage, among others. IMCAS is committed to the principle of transparency; therefore the disclosure of the grant allocation is available upon request. The next step In all cases, grantors are welcome to provide funds at any level without being tied to a minimal amount. You can provide a grant by making a request directly through the online platform. If you wish to receive more information on the granting process, please contact us at grants@imcas.com.

3 IMCAS KEY FIGURES * attendees 900 key speakers Geographical distribution and medical specialties of all IMCAS live and online attendees 5 meetings 550 hours of learning active web accounts 60% returning attendees (already attended IMCAS in the past) 52% EUROPE 6% NORTH AMERICA 15% MIDDLE EAST 5% ASIA 10% EASTERN EUROPE 5% LATIN AMERICA FOCUS ON EUROPE 98% of attendees plan to attend IMCAS in the future *per year - on imcas.com and academy.imcas.com 6% AFRICA 1% OCEANIA SPAIN 3,5% GERMANY 4,5% FRANCE 15% 3,5% UK ITALY 4,5% 4% GREECE 3,5% TURKEY

4 INTERNATIONAL ACADEMIC PARTNERSHIPS SCIENTIFIC SOCIETIES OF PLASTIC SURGERY AICPE Italian Association of Plastic and Aesthetic Surgery BAAPS British Association of Aesthetic Plastic Surgeons HKSPRAS Hong Kong Society of Plastic, Reconstructive and Aesthetic Surgeons (previous collaboration) HSPAS Ho Chi Minh Society of Plastic and Aesthetic Surgery (Vietnam) ISPAS Israel Society of Plastic and Aesthetic Surgery (in progress) LSPRAS Lebanese Society of Plastic, Reconstructive and Aesthetic Surgery SMCPRE Moroccan Society of Plastic, Reconstructive and Aesthetic Surgery SOMCEP Moroccan Society of Aesthetic Plastic Surgeons (in progress) SOFCEP French Society of Aesthetic Plastic Surgeons ThSPRS Society of Plastic and Reconstructive Surgeons of Thailand (previous collaboration) ThSAPS Society of Aesthetic Plastic Surgeons of Thailand (previous collaboration) TSPS Taiwan Society of Plastic Surgery SCIENTIFIC SOCIETIES OF FACIAL PLASTIC SURGERY SMRCPF Mexican Society of Rhinology and Facial Plastic Surgery TAFPRS Taiwan Academy of Facial Plastic and Reconstructive Surgery

5 INTERNATIONAL ACADEMIC PARTNERSHIPS SCIENTIFIC SOCIETIES OF DERMATOLOGY AMD Mexican Academy of Dermatology EDS Emirates Dermatology Society ESAD Egyptian Society of Aesthetic Dermatology ESLD European Society for Laser and Energy Based Devices GCSFD Surgical Group of the French Society of Dermatology (SFD) (in progress) GLSFD Laser Group of the French Society of Dermatology (SFD) GLSTDV Laser Group of the Tunisian Society of Dermatology and Venereology (STDV) JSAD Japanese Society of Aesthetic Dermatology PERDOSKI Indonesian Society of Dermatology and Venereology SMD Moroccan Society of Dermatology (in progress) SSDDS Saudi Society of Dermatology and Dermatologic Surgery TDA Taiwanese Dermatological Association SCIENTIFIC SOCIETIES OF AESTHETIC SCIENCE AAEGY Aesthetic Academy of Egypt ACCS Australasian College of Cosmetic Surgery ACG Aesthetic Consilium Group CSI Cell Society (previous collaboration) GRIRG Genital Restoration Innovative Research Group IPS International Peeling Society JSAS Japanese Society of Aesthetic Surgery THAICOSDERM Thai Society of Cosmetic Dermatology and Surgery

6 PAST AND ONGOING ACCREDITATIONS IMCAS ANNUAL WORLD CONGRESS PARIS UEMS - European Union of Medical Specialists ACCME - Accreditation Council for Continuing Medical Education DPC - National Agency of Continuing Professional Development IMCAS ASIA In Indonesia (Asia 2015) : IDI - Indonesian Medical Association In Taiwan (Asia 2016): TSPS - Taiwan Society of Plastic Sugery TDA - Taiwanese Dermatological Association TAFPRS - Taiwan Academy of Facial Plastic and Reconstructive Surgery IMCAS AMERICAS In Americas (America 2017) : SMRCPF - Mexican Society of Rhinology and Facial Plastic Surgery AMCPER - Mexican Association of Plastic, Reconstructive and Aesthetic Surgery AMD - Mexican Academy of Dermatology IMCAS INDIA In Goa (India 2015) : MCI - Goa Medical Council In Mumbai (India 2016) : MCI - Maharashtra Medical Council

7 LIVE 2017 SEASON S FUNDING OPPORTUNITIES: 3 LIVE - 3 ONLINE * Activity Date: Friday 27 January 2017 Activity Time: 10:30am Activity Duration: 1 hour Activity Venue: Palais des Congrès de Paris Activity Format: LIVE: chaired session with successive 6 to 20 min presentations with enduring material Program Description: This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology in relation to psoriasis. Review and assess various biologic options for psoriasis Evaluate the common therapy treatments and discuss the challenges physicians face when handling patients with the condition Explore the development of the latest phototherapy technology and devices for targeting psoriasis Target Audience The activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices who manage patients with psoriasis. Accreditation 1 AMA PRA Category 1 Credit(s) through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.) Educational Needs A substantial proportion of the US population has symptoms of psoriasis, which is 7.5 million 1, 2.2% of the population. Patients with psoriasis are at elevated risk to develop other medical conditions. For example, the incidence of psoriasis patients getting Crohn s disease and ulcerative colitis is 3.8 to 7.5 times greater than the general population. Activity Title n live 1/3: Clinical Dermatology Psoriasis Program Cost: Upon eligibility criteria Educational Objectives Upon completion of the educational activity, participants should be able to: Identify current trends in clinical dermatology Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy Review how to effectively detect and diagnose the symptoms and determine the best treatment options Assess current and emerging therapies for the condition Examine innovations in drug delivery methods Outcomes Measurements The assessment plan will be provided upon eligibility criteria Transparency The IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: OPEN PAYMENTS commonly known as the Sunshine Act, and internal IMCAS Compliance policies. Criteria for Success Statements of credit will be awarded based on the participant s attendance and submission of the activity evaluation form. REFERENCES 1 Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008 May;58(5): * IMCAS Annual World Congress 2017

8 LIVE Activity Title n live 2/3: Clinical Dermatology Innovations II Program Cost: Upon eligibility criteria Activity Date: Friday 27 January 2017 Activity Time: 1:30pm Activity Duration: 1 hour Activity Venue: Palais des Congrès de Paris Activity Format: LIVE: chaired session with successive 6 to 20 min presentations with enduring material Program Description: This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology, particularly in the area of: Broad usage of biologics Rosacea Atopic dermatitis Urticaria and itch Target Audience The activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology. Accreditation 1 AMA PRA Category 1 Credit(s) through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.) Educational Needs We often take it for granted that our skin function normally, but for those who suffer from skin conditions, their life is very different. At any given time, one in three people in the United States suffers from dermatological conditions; let it be acne, eczema or vitiligo. Having skin condition does not only affect the patients physical health, but the emotional and psychological health as well, ultimately impacting the qualify of life. Educational Objectives Upon completion of the educational activity, participants should be able to: Identify current trends in clinical dermatology Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy Review how to effectively detect and diagnose the symptoms and determine the best treatment options Assess current and emerging therapies for the condition Examine innovations in drug delivery methods Outcomes Measurements The assessment plan will be provided upon eligibility criteria Transparency The IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: OPEN PAYMENTS commonly known as the Sunshine Act, and internal IMCAS Compliance policies. Criteria for Success Statements of credit will be awarded based on the participant s attendance and submission of the activity evaluation form.

9 LIVE Activity Title n live 3/3: Clinical Dermatology Innovations III Program Cost: Upon eligibility criteria Activity Date: Friday 27 January 2017 Activity Time: 4:00pm Activity Duration: 1 hour Activity Venue: Palais des Congrès de Paris Activity Format: LIVE: chaired session with successive 6 to 20 min presentations with enduring material Program Description: This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology. Innovations in drug delivery Receive the latest information for new prescribed and non-prescribed treatment modalities What the future holds Share strategies for staying ahead and maintaining a successful practice in this ever-changing industry Innovations in the treatment of seborrheic keratosis Explore new and emerging techniques and devices Target Audience The activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology. Accreditation 1 AMA PRA Category 1 Credit(s) through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.) Educational Needs At the age of technology, our life is improving rapidly with all of the new concepts and gadgets available. And no doubt it also applies in the world of clinical dermatology as science and technology go hand in hand. Physicians have to stay on top in order to provide the most suitable and effective treatments to the patients. Educational Objectives Upon completion of the educational activity, participants should be able to: Identify current trends in clinical dermatology Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy Review how to effectively detect and diagnose the symptoms and determine the best treatment options Assess current and emerging therapies for the condition Examine innovations in drug delivery methods Outcomes Measurements The assessment plan will be provided upon eligibility criteria Transparency The IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: OPEN PAYMENTS commonly known as the Sunshine Act, and internal IMCAS Compliance policies. Criteria for Success Statements of credit will be awarded based on the participant s attendance and submission of the activity evaluation form.

10 ONLINE Activity Date: March 1, 2017 onwards Activity Expiry Date: March 1, 2018 Activity Duration: 1 hour Activity Format: ONLINE: Recorded chaired session with successive 6 to 20 min presentations with enduring material Program Description: This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology in relation to psoriasis. Review and assess various biologic options for psoriasis Evaluate the common therapy treatments and discuss the challenges physicians face when handling patients with the condition Explore the development of the latest phototherapy technology and devices for targeting psoriasis Target Audience The activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices who manage patients with psoriasis. Accreditation 1 AMA PRA Category 1 Credit(s) through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.) Educational Needs A substantial proportion of the US population has symptoms of psoriasis, which is 7.5 million 1, 2.2% of the population. Patients with psoriasis are at elevated risk to develop other medical conditions. For example, the incidence of psoriasis patients getting Crohn s disease and ulcerative colitis is 3.8 to 7.5 times greater than the general population. Activity Title n online 1/3: Clinical Dermatology Psoriasis Program Cost: Upon eligibility criteria Educational Objectives Upon completion of the educational activity, participants should be able to: Identify current trends in clinical dermatology Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy Review how to effectively detect and diagnose the symptoms and determine the best treatment options Assess current and emerging therapies for the condition Examine innovations in drug delivery methods Outcomes Measurements The assessment plan will be provided upon eligibility criteria Transparency The IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: OPEN PAYMENTS commonly known as the Sunshine Act, and internal IMCAS Compliance policies. Criteria for Success Statements of credit will be awarded based on the participant s attendance and submission of the activity evaluation form. REFERENCES 1 Menter A, Gottlieb A, Feldman SR, Van Voorhees AS et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008 May;58(5):

11 ONLINE Activity Title n online 2/3: Clinical Dermatology Innovations II Program Cost: Upon eligibility criteria Activity Date: March 1, 2017 onwards Activity Expiry Date: March 1, 2018 Activity Duration: 1 hour Activity Format: ONLINE: Recorded chaired session with successive 6 to 20 min presentations with enduring material Program Description: This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology, particularly in the area of: Broad usage of biologics Rosacea Atopic dermatitis Urticaria and itch Target Audience The activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology. Accreditation 1 AMA PRA Category 1 Credit(s) through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.) Educational Needs We often take it for granted that our skin function normally, but for those who suffer from skin conditions, their life is very different. At any given time, one in three people in the United States suffers from dermatological conditions; let it be acne, eczema or vitiligo. Having skin condition does not only affect the patients physical health, but the emotional and psychological health as well, ultimately impacting the qualify of life. Educational Objectives Upon completion of the educational activity, participants should be able to: Identify current trends in clinical dermatology Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy Review how to effectively detect and diagnose the symptoms and determine the best treatment options Assess current and emerging therapies for the condition Examine innovations in drug delivery methods Outcomes Measurements The assessment plan will be provided upon eligibility criteria Transparency The IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: OPEN PAYMENTS commonly known as the Sunshine Act, and internal IMCAS Compliance policies. Criteria for Success Statements of credit will be awarded based on the participant s attendance and submission of the activity evaluation form.

12 ONLINE Activity Title n online 3/3: Clinical Dermatology Innovations III Program Cost: Upon eligibility criteria Activity Date: March 1, 2017 onwards Activity Expiry Date: March 1, 2018 Activity Duration: 1 hour Activity Format: ONLINE: Recorded chaired session with successive 6 to 20 min presentations with enduring material Program Description: This session has been constructed in order to provide practitioners clear and precise data aimed at understanding the main challenges faced by doctors, and find the best solutions to improve patient outcome in the field of clinical dermatology. Innovations in drug delivery Receive the latest information for new prescribed and non-prescribed treatment modalities What the future holds Share strategies for staying ahead and maintaining a successful practice in this ever-changing industry Innovations in the treatment of seborrheic keratosis Explore new and emerging techniques and devices Target Audience The activity is designed to meet the needs of all healthcare professionals concerned, i.e. physicians, nurses, and professional staff members of medical practices specializing in clinical dermatology. Accreditation 1 AMA PRA Category 1 Credit(s) through (obtained through a joint providership with Advanced Knowledge in Healthcare - AKH Inc.) Educational Needs At the age of technology, our life is improving rapidly with all the new concepts and gadgets available. And no doubt it also applies in the world of clinical dermatology as science and technology go hand in hand. Physicians have to stay on top in order to provide the most suitable and effective treatments to the patients. Educational Objectives Upon completion of the educational activity, participants should be able to: Identify current trends in clinical dermatology Discuss the current indications, limitations, and potential uses for photodynamic or superficial radiation therapy Review how to effectively detect and diagnose the symptoms and determine the best treatment options Assess current and emerging therapies for the condition Examine innovations in drug delivery methods Outcomes Measurements The assessment plan will be provided upon eligibility criteria Transparency The IMCAS Educational Grant process is in full accordance with the recommendations and the guidance of the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: OPEN PAYMENTS commonly known as the Sunshine Act, and internal IMCAS Compliance policies. Criteria for Success Statements of credit will be awarded based on the participant s attendance and submission of the activity evaluation form.